Opportunity
SAM #7571TE26Q00038
FDA Sole Source Procurement of Molecular Operating Environment (MOE) Software from Chemical Computing Group ULC
Buyer
OMAS STRATEGIC BUYING CENTER - INFORMATION TECHNOLOGY
Posted
June 09, 2026
Respond By
June 16, 2026
Identifier
7571TE26Q00038
NAICS
513210, 511210
This opportunity involves the FDA's intent to procure advanced molecular modeling software for drug evaluation purposes. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Department of Health and Human Services (HHS) - Office of the Assistant Secretary for Financial Resources (ASFR) - OMAS Strategic Buying Center - Information Technology - OEM Highlight: - Chemical Computing Group ULC is the sole OEM and vendor for this procurement - Products/Services Requested: - Molecular Operating Environment (MOE) software platform - Comprehensive cheminformatics and molecular modeling solution - Enables advanced 3D structural analysis and representation - Supports customizable molecular docking models - Includes computational models for updating chemical descriptors - Provides chemical database management - Capable of modeling organic, metallic, and biomolecules - Notable Requirements: - Software must support robust evaluation of adverse drug reactions using 3D modeling - Only Chemical Computing Group ULC can provide the required licensing and warranty coverage - Contract includes a base year plus four one-year option periods (total five years) - No specific product part numbers or quantities were provided in the summary
Description
NOTICE OF INTENT TO SOLE SOURCE
The U.S. Food and Drug Administration intends to award a sole source contract to Chemical Computing Group ULC to enhance the Division of Applied Regulatory Science (DARS) analytical capabilities beyond traditional two-dimensional (2D) methods. The Molecular Operating Environment (MOE), a comprehensive cheminformatics and molecular modeling software platform enables three-dimensional (3D) structural analysis and representation, which has proven essential for conducting more robust evaluations of adverse drug reactions that cannot be adequately assessed through 2D approaches alone.
The anticipated period of performance will consist of a base year, plus four one-year option periods.
Base Period : 06/29/2026 to 06/28/2027
Option Period One: 06/29/2027 to 06/28/2028
Option Period Two: 06/29/2028 to 06/28/2029
Option Period Three: 06/29/2029 to 06/28/2030
Option Period Four: 06/29/2030 to 06/28/2031
The award will be a single source procurement awarded to Chemical Computing Group ULC, in accordance with RFO-FAR 6.103-1 Only one responsible source and no other supplies or services will satisfy agency requirements. Contracting Officers may solicit from only one source if the circumstances of the contract action deem that only one source is reasonably available based on licensing agreements and warranty coverage on specialized equipment.
Only one source, Chemical Computing Group ULC, is capable of fulfilling the Government’s requirement to provide the molecular modeling software package to communicate and provide customizable molecular docking models, computational models updating chemical descriptors, support chemical database management, and provide modeling diverse types of molecules and molecular interactions (organic, metallic, biomolecules).
This notice is not a solicitation or a request for offers. Any potential sources other than Chemical Computing Group ULC may submit a capability statement via email to Carlton Taylor, at carlton.taylor@hhs.gov by 12:00 PM EST on Tuesday June 16, 2026.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Oral communications are not acceptable in response to this notice.
A determination by the Government not to compete the proposed procurement based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A solicitation will not be issued.